SQLE and osteosarcoma: These studies suggest that MLH1 may act as a protective factor, with higher expression potentially reducing the risk and improving the prognosis of osteosarcoma patients, while SQLE may serve as a risk factor, with its higher expression possibly increasing the prognosis risk for osteosarcoma patients.